CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
1-Year Return
85.27%
This Quarter Return
+27.21%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.15B
AUM Growth
+$292M
(+34%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
11.21%
Top 10 Holdings %
Top 10 Hldgs %
65.7%
Holding
58
New
9
Increased
8
Reduced
26
Closed
9
Top Buys
| 1 |
Nektar Therapeutics
NKTR
|
$60.1M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$38.6M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
$28.5M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$21.1M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$20M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$25.1M |
| 2 |
KA
Kineta, Inc. Common Stock
KA
|
$19.2M |
| 3 |
AnaptysBio
ANAB
|
$15.3M |
| 4 |
BLUE
bluebird bio
BLUE
|
$14.2M |
| 5 |
Wave Life Sciences
WVE
|
$7.09M |
Sector Composition
| 1 | Healthcare | 96.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
51
DELISTED
bluebird bio
BLUE
| – | – |
-6,176
| Closed | -$14.2M |
|
52
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-11,822
| Closed | -$4.86M |
|
53
Outlook Therapeutics
OTLK
$38.8M
| – | – |
-191
| Closed | -$40K |
|
54
Ovid Therapeutics
OVID
$93.9M
| – | – |
-223,972
| Closed | -$2.21M |
|
|
55
Wave Life Sciences
WVE
$1.27B
| – | – |
-202,079
| Closed | -$7.09M |
|
|
SYRS
56
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – |
-29,630
| Closed | -$2.88M |
|
|
KA
57
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
-23,571
| Closed | -$19.2M |
|
|
JUNO
58
DELISTED
Juno Therapeutics, Inc.
JUNO
| – | – |
-550,000
| Closed | -$25.1M |
|